CLAZF OTC
Claritas Pharmaceuticals, Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -99.0%
1Y: -99.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.0001
Volume250
Avg Volume231
Beta2.12
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORobert Farrell
Employees3
SectorHealthcare
IndustryBiotechnology
IPO Date2016-04-12
Websiteclaritaspharma.com
4040 Civic Center Drive
San Rafael, CA 94903
US
San Rafael, CA 94903
US
888 861 2008
About Claritas Pharmaceuticals, Inc.
Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Claritas Pharmaceuticals, Inc. in April 2021. Its corporate headquarters are located in San Rafael, California.
Latest News
No recent news
Recent Insider Trades
No insider trades found